Driving T-cell immunotherapy to solid tumors

Nature Biotechnology 36, 215 (2018).
doi:10.1038/nbt.4090

Author: Ken Garber
T cell receptor (TCR) gene therapy can target the immune system to solid tumors in ways CAR-T cells can't match, but the field is still looking for a clear success. Ken Garber reports.

Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Ken Garber Tags: News Source Type: research